Thomson Reuters | Free Resources

Quarterly Reports
White Papers
Newsletters
More

Thomson Reuters' series of reviews covering all aspects of the pharmaceutical marketplace, Pharma Matters.

CUTTING EDGE OF CHEMISTRY

An action-packed review of the latest chemistry shaping today's drug discovery and development pipeline. Subscribe & Download

MOVERS AND SHAKERS

An insightful review of the generics industry unraveling the most significant game play in this exciting area. Subscribe & Download

THE ONES TO WATCH

A topical review of the most promising drugs reaching the market and moving between clinical trials. Subscribe & Download

SPOTLIGHT ON...

An exciting review of the key market players and deals highlights for leading areas of industry investment and development. Subscribe & Download

THOMSON REUTERS' WHITE PAPERS COVERING THE PHARMACEUTICAL MARKETPLACE.

Creating a Patient-based Forecast

Thomson Reuters takes a deeper look at the role of forecasting and the factors to consider in developing a patient-based forecast such as prevalence and incidence of the disease, patient population and eligibility, market share, likelihood of approval data, and benchmarking. Download

The Promise of Imaging Biomarkers

Thomson Reuters provides a snapshot of the imaging biomarkers at use in research and development, and the clinic; examines key technical and commercialization challenges; and identifies promising avenues for progress in the field with insight from experts from industry and academia. Download

The Japanese Generic Drug Market: Opportunities and Strategies for Success

Thomson Reuters reveals the true picture of the generic market in Japan, predicts how it may change under the DPJ administration, and details the tactics that companies must follow to ensure success in this market. Download

Establishing the Standards in Biomarker Research

We show how the pharmaceutical industry is already beginning to rely on biomarker information, and explain how important it is to establish the standards that will support increasing biomarker implementation in the future. Download

Biomarkers: An Indispensable Addition to the Drug Development Toolkit

We explore the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents. The potential of biomarkers to improve decision making, accelerate drug development and reduce development costs is discussed with insight from experts in industry and academia. Download

Also check out what Dr. Jeffery Ross has to say about Biomarkers by watching Biomarkers, Drug Development and the Advent of Personalized Medicine Presented by Dr Jeffery Ross, Albany Medical College, New York

Key Opinion Leader Identification and Selection

Objectively identifying key opinion leaders (KOLs), scientific experts or clinical investigators to collaborate with can be an onerous task.

Thomson Reuters discusses the regulatory aspects of the KOL / industry relationship, proposes a primary means of determining KOL relevance, discusses methods for identifying KOLs to suit your business strategy, and proposes a solution for optimal KOL identification and selection. Download

10 Ways to Influence the Market

The role of every brand manager, regardless of industry, is to ensure their company's voice is heard over the background noise of the marketplace.

Unlike other industries, however, guaranteeing a positive reception for a new pharmaceutical product isn't just a case of spending the most on advertising or sponsorship. There are strategies you must adopt in order to influence the market positively and make sure you realize the greatest possible return on your investment. Download PDF